A phase I trial of autologous CD34+ hematopoietic progenitor cells transduced with an anti-HIV ribozyme

Hum Gene Ther. 1999 Sep 1;10(13):2255-70. doi: 10.1089/10430349950017239.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I

MeSH terms

  • Adolescent
  • Adult
  • Antigens, CD34*
  • Cells, Cultured
  • Clinical Protocols
  • Gene Products, tat / genetics*
  • Genetic Therapy*
  • HIV Infections / therapy*
  • HIV Infections / virology
  • Hematopoietic Stem Cells / immunology
  • Hematopoietic Stem Cells / metabolism*
  • Human Experimentation
  • Humans
  • Middle Aged
  • RNA, Catalytic / genetics*
  • tat Gene Products, Human Immunodeficiency Virus

Substances

  • Antigens, CD34
  • Gene Products, tat
  • RNA, Catalytic
  • tat Gene Products, Human Immunodeficiency Virus